Skip to main content
Premium Trial:

Request an Annual Quote

Roche Expanding German Diagnostics Facility

NEW YORK (GenomeWeb News) – Roche announced today that it is investing 215 million Swiss francs ($191.7 million) in expanding its research, development, and production operations in Germany for its Applied Science and Professional Diagnostics businesses.
The money will be used to construct a multi-purpose building for Roche Diagnostics in Penzberg, near Munich, the firm said. From around mid-2010, the complex is expected to manufacture products ranging from biotech constituents for immunodiagnostics and life sciences research through complete immunodiagnostic test kits, which are used worldwide on Roche’s Cobas and Elecsys instruments.
The firm said that the expansion of production capacity for its Applied Science business is a reaction to “the sustained growth in demand for research reagents, including LightCycler real-time PCR systems.”

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.